| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 16 | 2017 | 22 | 3.020 |
Why?
|
| Hippocampus | 23 | 2015 | 459 | 2.550 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2021 | 116 | 2.480 |
Why?
|
| Microglia | 12 | 2021 | 124 | 2.130 |
Why?
|
| Exosomes | 5 | 2016 | 60 | 2.030 |
Why?
|
| Oxidative Stress | 8 | 2021 | 473 | 2.010 |
Why?
|
| Neocortex | 6 | 2017 | 106 | 1.700 |
Why?
|
| Rats, Wistar | 24 | 2021 | 309 | 1.480 |
Why?
|
| Astrocytes | 15 | 2021 | 151 | 1.450 |
Why?
|
| Rats | 53 | 2021 | 4155 | 1.450 |
Why?
|
| Myelin Sheath | 5 | 2021 | 85 | 1.400 |
Why?
|
| Migraine Disorders | 3 | 2021 | 42 | 1.320 |
Why?
|
| Trigeminal Ganglion | 2 | 2021 | 16 | 1.300 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2021 | 39 | 1.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2014 | 712 | 1.170 |
Why?
|
| Neurons | 10 | 2021 | 1654 | 1.110 |
Why?
|
| Interferon-gamma | 5 | 2021 | 462 | 1.010 |
Why?
|
| Neuroprotective Agents | 3 | 2017 | 102 | 0.850 |
Why?
|
| Central Nervous System | 2 | 2016 | 153 | 0.830 |
Why?
|
| Environment | 2 | 2016 | 233 | 0.780 |
Why?
|
| Animals | 69 | 2021 | 28901 | 0.780 |
Why?
|
| Evoked Potentials | 5 | 2012 | 202 | 0.730 |
Why?
|
| MicroRNAs | 6 | 2021 | 591 | 0.720 |
Why?
|
| Oligodendroglia | 5 | 2021 | 122 | 0.690 |
Why?
|
| Nitroglycerin | 1 | 2021 | 24 | 0.680 |
Why?
|
| Tissue Culture Techniques | 4 | 2015 | 81 | 0.620 |
Why?
|
| Cytokines | 6 | 2014 | 871 | 0.600 |
Why?
|
| Signal Transduction | 6 | 2014 | 3581 | 0.560 |
Why?
|
| Organ Culture Techniques | 10 | 2013 | 128 | 0.550 |
Why?
|
| Membrane Potentials | 7 | 2014 | 442 | 0.520 |
Why?
|
| Dendritic Cells | 3 | 2021 | 539 | 0.510 |
Why?
|
| Demyelinating Diseases | 2 | 2013 | 51 | 0.510 |
Why?
|
| Brain Ischemia | 8 | 2001 | 416 | 0.460 |
Why?
|
| Cells, Cultured | 10 | 2016 | 2928 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2021 | 67 | 0.450 |
Why?
|
| Leukocytes | 1 | 2016 | 213 | 0.440 |
Why?
|
| Interleukin-11 | 2 | 2014 | 20 | 0.440 |
Why?
|
| Immunohistochemistry | 14 | 2013 | 1827 | 0.420 |
Why?
|
| Pyramidal Cells | 2 | 2005 | 89 | 0.410 |
Why?
|
| Gliosis | 4 | 2016 | 32 | 0.410 |
Why?
|
| Cold Temperature | 2 | 2010 | 162 | 0.400 |
Why?
|
| Interferon-alpha | 1 | 2013 | 194 | 0.390 |
Why?
|
| Brain | 13 | 2021 | 2479 | 0.390 |
Why?
|
| Immunologic Factors | 1 | 2014 | 176 | 0.370 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 126 | 0.360 |
Why?
|
| Animals, Newborn | 6 | 2013 | 535 | 0.350 |
Why?
|
| Calcium | 6 | 2004 | 1205 | 0.350 |
Why?
|
| Inflammation | 3 | 2016 | 1063 | 0.350 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 264 | 0.350 |
Why?
|
| Administration, Intranasal | 3 | 2021 | 140 | 0.340 |
Why?
|
| Models, Immunological | 1 | 2011 | 85 | 0.340 |
Why?
|
| Bicarbonates | 6 | 1994 | 58 | 0.340 |
Why?
|
| Extracellular Space | 9 | 1994 | 90 | 0.330 |
Why?
|
| Depression | 1 | 2015 | 562 | 0.330 |
Why?
|
| Microelectrodes | 8 | 2014 | 98 | 0.330 |
Why?
|
| Cerebral Cortex | 7 | 1996 | 615 | 0.330 |
Why?
|
| Hydrogen-Ion Concentration | 17 | 1994 | 509 | 0.320 |
Why?
|
| Intracellular Fluid | 5 | 1991 | 34 | 0.320 |
Why?
|
| Models, Neurological | 2 | 2011 | 435 | 0.310 |
Why?
|
| Electric Stimulation | 7 | 2012 | 398 | 0.300 |
Why?
|
| Trigeminal Caudal Nucleus | 2 | 2003 | 3 | 0.290 |
Why?
|
| Interleukin-1 | 2 | 1999 | 71 | 0.290 |
Why?
|
| Cell Movement | 2 | 2011 | 816 | 0.280 |
Why?
|
| Phosphopyruvate Hydratase | 4 | 2012 | 43 | 0.270 |
Why?
|
| Endocytosis | 1 | 2008 | 186 | 0.270 |
Why?
|
| Male | 28 | 2021 | 45792 | 0.270 |
Why?
|
| Cell Death | 3 | 2011 | 264 | 0.270 |
Why?
|
| Microspheres | 2 | 2004 | 105 | 0.260 |
Why?
|
| In Vitro Techniques | 4 | 2014 | 1014 | 0.260 |
Why?
|
| Chloride Channels | 2 | 1998 | 43 | 0.260 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 481 | 0.250 |
Why?
|
| Dinoprostone | 3 | 2008 | 75 | 0.250 |
Why?
|
| Hyperglycemia | 4 | 1997 | 181 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 1996 | 37 | 0.240 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2010 | 59 | 0.230 |
Why?
|
| Acid-Base Equilibrium | 5 | 1997 | 35 | 0.230 |
Why?
|
| Myelin Basic Protein | 2 | 2016 | 47 | 0.230 |
Why?
|
| Potassium Chloride | 4 | 2017 | 88 | 0.210 |
Why?
|
| Rats, Inbred Strains | 13 | 1991 | 311 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 1267 | 0.210 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 80 | 0.210 |
Why?
|
| Glutathione | 2 | 2015 | 107 | 0.210 |
Why?
|
| Axons | 3 | 2016 | 189 | 0.210 |
Why?
|
| N-Methylaspartate | 4 | 2012 | 50 | 0.210 |
Why?
|
| Acidosis | 4 | 2001 | 56 | 0.210 |
Why?
|
| Body Fluids | 3 | 1989 | 35 | 0.200 |
Why?
|
| Potassium | 5 | 1991 | 271 | 0.200 |
Why?
|
| Neurotoxins | 2 | 2008 | 48 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 380 | 0.200 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 2059 | 0.200 |
Why?
|
| Cerebellum | 6 | 1988 | 253 | 0.190 |
Why?
|
| Migraine with Aura | 1 | 2003 | 4 | 0.190 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 127 | 0.190 |
Why?
|
| Calcium Signaling | 1 | 2004 | 142 | 0.190 |
Why?
|
| Calcium Channels | 1 | 2004 | 183 | 0.190 |
Why?
|
| Brain Diseases | 2 | 2017 | 193 | 0.190 |
Why?
|
| Lactates | 7 | 1989 | 39 | 0.190 |
Why?
|
| Pregnancy | 4 | 2013 | 3239 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2013 | 43 | 0.180 |
Why?
|
| Minocycline | 2 | 2014 | 15 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 205 | 0.180 |
Why?
|
| Synapses | 2 | 2011 | 291 | 0.180 |
Why?
|
| Carbon Dioxide | 5 | 1994 | 213 | 0.170 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 305 | 0.170 |
Why?
|
| Antibodies | 2 | 2014 | 356 | 0.170 |
Why?
|
| Electrophysiology | 7 | 2004 | 408 | 0.170 |
Why?
|
| Neuroglia | 3 | 2017 | 105 | 0.170 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 47 | 0.160 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 5 | 0.160 |
Why?
|
| Nerve Net | 1 | 2004 | 407 | 0.160 |
Why?
|
| Stem Cells | 2 | 2013 | 394 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1533 | 0.150 |
Why?
|
| Analysis of Variance | 2 | 2012 | 909 | 0.150 |
Why?
|
| Time Factors | 5 | 2012 | 5593 | 0.150 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1999 | 5 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 4 | 2005 | 402 | 0.140 |
Why?
|
| Hydrogen | 3 | 1989 | 53 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 1309 | 0.140 |
Why?
|
| Trigeminal Nuclei | 1 | 1998 | 4 | 0.140 |
Why?
|
| 4-Aminopyridine | 1 | 1998 | 37 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2013 | 1662 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 1966 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2012 | 45 | 0.140 |
Why?
|
| Action Potentials | 4 | 2012 | 629 | 0.140 |
Why?
|
| Potassium Channel Blockers | 1 | 1998 | 67 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2088 | 0.140 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 123 | 0.130 |
Why?
|
| Random Allocation | 1 | 2017 | 321 | 0.130 |
Why?
|
| Lipoxygenase | 1 | 1996 | 9 | 0.130 |
Why?
|
| Nasal Mucosa | 1 | 2017 | 196 | 0.130 |
Why?
|
| Eicosanoids | 1 | 1996 | 17 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 137 | 0.120 |
Why?
|
| Isoenzymes | 1 | 1996 | 278 | 0.120 |
Why?
|
| Female | 9 | 2021 | 49980 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 286 | 0.110 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 262 | 0.110 |
Why?
|
| Ion Channel Gating | 1 | 1998 | 338 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 655 | 0.110 |
Why?
|
| Benzylidene Compounds | 1 | 2014 | 2 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2014 | 21 | 0.110 |
Why?
|
| Spleen | 1 | 2016 | 419 | 0.110 |
Why?
|
| Actins | 1 | 1998 | 472 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 1996 | 281 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2014 | 62 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 15 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 1994 | 120 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 161 | 0.110 |
Why?
|
| Rats, Inbred WKY | 1 | 2013 | 31 | 0.100 |
Why?
|
| Lysophosphatidylcholines | 1 | 2013 | 17 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2014 | 51 | 0.100 |
Why?
|
| Tissue Fixation | 1 | 2013 | 40 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 69 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 53 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 243 | 0.100 |
Why?
|
| Quantum Dots | 1 | 2012 | 20 | 0.100 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 5 | 0.090 |
Why?
|
| Intracellular Membranes | 2 | 1990 | 117 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2016 | 554 | 0.090 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1991 | 8 | 0.090 |
Why?
|
| Cerebellar Nuclei | 1 | 1991 | 6 | 0.090 |
Why?
|
| Oxidants | 1 | 2012 | 86 | 0.090 |
Why?
|
| Biophysics | 1 | 2012 | 157 | 0.090 |
Why?
|
| Serum | 1 | 2012 | 25 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 165 | 0.090 |
Why?
|
| Plant Lectins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Endotoxins | 1 | 2011 | 38 | 0.090 |
Why?
|
| Neural Pathways | 2 | 2004 | 333 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 760 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2011 | 76 | 0.090 |
Why?
|
| Paracrine Communication | 1 | 2011 | 32 | 0.090 |
Why?
|
| Indoles | 1 | 1993 | 317 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 93 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 96 | 0.080 |
Why?
|
| Muscles | 1 | 1991 | 192 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 22 | 0.080 |
Why?
|
| Cerebral Infarction | 2 | 1991 | 74 | 0.080 |
Why?
|
| Cell Shape | 1 | 2011 | 50 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 1319 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2013 | 356 | 0.080 |
Why?
|
| Sulfonamides | 1 | 1993 | 337 | 0.080 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 23 | 0.080 |
Why?
|
| Organic Chemicals | 1 | 2010 | 37 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 516 | 0.080 |
Why?
|
| Cell Count | 2 | 2003 | 202 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 432 | 0.070 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 5 | 0.070 |
Why?
|
| Ectodysplasins | 1 | 2008 | 5 | 0.070 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2008 | 29 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 766 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2011 | 171 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2004 | 796 | 0.070 |
Why?
|
| Electric Fish | 1 | 1988 | 19 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 88 | 0.070 |
Why?
|
| Proteins | 1 | 2014 | 816 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 1988 | 84 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2534 | 0.070 |
Why?
|
| Functional Laterality | 2 | 2003 | 208 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 983 | 0.070 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1998 | 18 | 0.070 |
Why?
|
| Ammonia | 1 | 1987 | 45 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 2001 | 71 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 1987 | 109 | 0.060 |
Why?
|
| Insulin | 1 | 2012 | 1191 | 0.060 |
Why?
|
| Chlorides | 3 | 1994 | 108 | 0.060 |
Why?
|
| Zinc | 2 | 1998 | 101 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2008 | 252 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 740 | 0.060 |
Why?
|
| Carbonic Acid | 1 | 1986 | 1 | 0.060 |
Why?
|
| Carbonates | 1 | 1986 | 5 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 329 | 0.060 |
Why?
|
| Fishes | 3 | 1978 | 145 | 0.060 |
Why?
|
| Glucose | 1 | 2008 | 702 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 15 | 0.060 |
Why?
|
| Styrenes | 1 | 2005 | 7 | 0.060 |
Why?
|
| Lactic Acid | 4 | 1989 | 108 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 311 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 1987 | 516 | 0.050 |
Why?
|
| Sodium Acetate | 1 | 2004 | 1 | 0.050 |
Why?
|
| Immunoassay | 1 | 2004 | 100 | 0.050 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2004 | 8 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 51 | 0.050 |
Why?
|
| Calcium Channels, P-Type | 1 | 2004 | 10 | 0.050 |
Why?
|
| Dentate Gyrus | 1 | 2004 | 33 | 0.050 |
Why?
|
| Reference Standards | 1 | 2004 | 150 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 190 | 0.050 |
Why?
|
| Vasodilator Agents | 2 | 2011 | 151 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 123 | 0.050 |
Why?
|
| Hypoxia | 1 | 2008 | 681 | 0.050 |
Why?
|
| Homeostasis | 2 | 2004 | 466 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 84 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 675 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2004 | 725 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 233 | 0.050 |
Why?
|
| Seizures | 1 | 2004 | 331 | 0.040 |
Why?
|
| Cervical Cord | 1 | 2021 | 16 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2021 | 66 | 0.040 |
Why?
|
| Blood Glucose | 1 | 1985 | 873 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 476 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 145 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 314 | 0.040 |
Why?
|
| Biological Transport | 2 | 2017 | 412 | 0.040 |
Why?
|
| Buffers | 2 | 1991 | 26 | 0.040 |
Why?
|
| Menstruation-Inducing Agents | 1 | 1999 | 1 | 0.040 |
Why?
|
| Fura-2 | 1 | 1999 | 22 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1999 | 42 | 0.040 |
Why?
|
| Sodium | 2 | 1978 | 340 | 0.040 |
Why?
|
| Adenylyl Cyclases | 1 | 1999 | 106 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1998 | 18 | 0.040 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 17 | 0.040 |
Why?
|
| Humans | 3 | 2017 | 95992 | 0.040 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1998 | 23 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 1998 | 15 | 0.030 |
Why?
|
| Phalloidine | 1 | 1998 | 9 | 0.030 |
Why?
|
| Gelsolin | 1 | 1998 | 11 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1999 | 283 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1998 | 22 | 0.030 |
Why?
|
| Cell Size | 1 | 1998 | 71 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1998 | 147 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 223 | 0.030 |
Why?
|
| Masoprocol | 1 | 1996 | 3 | 0.030 |
Why?
|
| Quinacrine | 1 | 1996 | 10 | 0.030 |
Why?
|
| Oxygen | 2 | 1993 | 781 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1996 | 32 | 0.030 |
Why?
|
| Phenylephrine | 1 | 1996 | 36 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1996 | 40 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 897 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 34 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 1996 | 35 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1996 | 36 | 0.030 |
Why?
|
| Indomethacin | 1 | 1996 | 62 | 0.030 |
Why?
|
| Mitochondria | 1 | 2001 | 621 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 128 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 1996 | 100 | 0.030 |
Why?
|
| Entorhinal Cortex | 1 | 1995 | 16 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1996 | 350 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1995 | 80 | 0.030 |
Why?
|
| Ion-Selective Electrodes | 1 | 1994 | 5 | 0.030 |
Why?
|
| Amygdala | 1 | 1995 | 87 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1996 | 369 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1991 | 488 | 0.030 |
Why?
|
| Sumatriptan | 1 | 1993 | 2 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 1993 | 32 | 0.020 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1993 | 15 | 0.020 |
Why?
|
| Genes, fos | 1 | 1993 | 24 | 0.020 |
Why?
|
| Meninges | 1 | 1993 | 14 | 0.020 |
Why?
|
| Microinjections | 1 | 1993 | 71 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1993 | 48 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1993 | 90 | 0.020 |
Why?
|
| Luminescence | 1 | 2012 | 20 | 0.020 |
Why?
|
| Motor Cortex | 1 | 1995 | 215 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1993 | 78 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1993 | 197 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 138 | 0.020 |
Why?
|
| Logistic Models | 1 | 1996 | 1273 | 0.020 |
Why?
|
| Endosomes | 1 | 2012 | 86 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1991 | 18 | 0.020 |
Why?
|
| Kinetics | 2 | 1991 | 1561 | 0.020 |
Why?
|
| Capillaries | 1 | 1991 | 85 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1991 | 85 | 0.020 |
Why?
|
| Electrodes | 1 | 1991 | 103 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 89 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 198 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 297 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2011 | 257 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 227 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1991 | 131 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 420 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 312 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 166 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 1991 | 118 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 376 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1990 | 35 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 203 | 0.020 |
Why?
|
| Beverages | 1 | 1969 | 16 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 287 | 0.020 |
Why?
|
| Cell Survival | 2 | 2008 | 1029 | 0.020 |
Why?
|
| Barium | 1 | 1989 | 32 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 1991 | 168 | 0.020 |
Why?
|
| Rest | 1 | 1989 | 53 | 0.020 |
Why?
|
| Cell Division | 1 | 1990 | 701 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 671 | 0.020 |
Why?
|
| Cinnamates | 1 | 2008 | 8 | 0.020 |
Why?
|
| Thiourea | 1 | 2008 | 10 | 0.020 |
Why?
|
| Caffeine | 1 | 1969 | 85 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Gene Expression | 1 | 1993 | 1319 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 31 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1991 | 425 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 1990 | 514 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 139 | 0.020 |
Why?
|
| Cholesterol | 1 | 1969 | 367 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 191 | 0.020 |
Why?
|
| Immunity | 1 | 2008 | 155 | 0.020 |
Why?
|
| Protons | 1 | 1987 | 104 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 926 | 0.020 |
Why?
|
| Partial Pressure | 1 | 1986 | 51 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1986 | 181 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 1156 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 412 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3642 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1753 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 1756 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1985 | 297 | 0.010 |
Why?
|
| United States | 1 | 2017 | 7785 | 0.010 |
Why?
|
| Glioma | 1 | 1986 | 321 | 0.010 |
Why?
|
| Acetazolamide | 1 | 1983 | 11 | 0.010 |
Why?
|
| Manganese | 1 | 1983 | 57 | 0.010 |
Why?
|
| Mammals | 1 | 1985 | 261 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 2575 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 3483 | 0.010 |
Why?
|
| Ischemia | 1 | 1983 | 256 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1986 | 848 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1810 | 0.010 |
Why?
|
| Sucrose | 2 | 1991 | 67 | 0.010 |
Why?
|
| Electrolytes | 1 | 1978 | 53 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1978 | 121 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 1976 | 12 | 0.010 |
Why?
|
| Monensin | 1 | 1976 | 16 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 12525 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1991 | 33 | 0.010 |
Why?
|
| Body Water | 1 | 1991 | 35 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1991 | 82 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1969 | 6 | 0.000 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1969 | 8 | 0.000 |
Why?
|
| Cholelithiasis | 1 | 1969 | 36 | 0.000 |
Why?
|
| Tea | 1 | 1969 | 19 | 0.000 |
Why?
|
| Hydrochloric Acid | 1 | 1989 | 11 | 0.000 |
Why?
|
| Solutions | 1 | 1987 | 86 | 0.000 |
Why?
|
| Injections | 1 | 1987 | 127 | 0.000 |
Why?
|
| Necrosis | 1 | 1987 | 212 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1987 | 132 | 0.000 |
Why?
|
| Dimethadione | 1 | 1986 | 1 | 0.000 |
Why?
|
| Autoradiography | 1 | 1986 | 68 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1986 | 165 | 0.000 |
Why?
|
| Cats | 1 | 1978 | 305 | 0.000 |
Why?
|